I. INTRODUCTION
It has been reported previously that poly-oestradiol phosphate (hereafter PEP) a water soluble high molecular weight polyester of phosphoric acid and oestradiol-17\g=b\produces a greatly prolonged oestrogenic effect as measured by the mouse vaginal smear technique (Diczfalusy, 1954) . This occasions, a mean value of 7.7 counts/min., with a variance of 0.264 was cal¬ culated. At this level (7.7 counts/min.) the variance depending on G.-M. tube counting would be 0.053. The ratio of variances (F = 0.264/0.053 = 4.9) is significant on the 99.9 per cent probability level (nj: 226, no: 29) . Thus it would appear that the day to day variation in background exceeds significantly the variation depending on G.-M. counting. Therefore it was considered to be better to use the background values obtained daily.
Correction for decay of radioactivity.
All the radioactivity data presented in this study refer to the activity on the first day of experiment. They were cal¬ culated according to the general formula for decay of 32P.
In order to ascertain that the radioactivity incorporated in our preparation consisted of 32P, the decay of PE32P was estimated experimentally, as shown in Fig. 1 .
The value of the regression coefficient (0.021) shown in Fig. 1 Since each of the 37 estimates shown in Fig. 1 is based only on 300 counts, the G.-M. tube counting error must also be estimated at the 300-counts level. Therefore the U3O8 standard previously used for the estimation of G.-M. tube counting error at the 6000-counts level, was counted again 30 Fig. 2 B) and 2) that the true relationship between the cubic root of days and log counts is linear (as shown in Fig. 2 C) . Bartlett's test (1937) to the data. Since on no occasion was it possible to obtain significant evidence of heterogeneity, the application of regression equations to the data of the present study appeared justifiable.
Thus the equation of the 32P-line can be estimated as Y = 1.627-0.100 ( -3.706) Analysis of variance for the data of Table 5 .
The last two columns of Fig. 3 , where the logarithms of counts found in the liver of PE32P-treated animals are plotted against the cubic root of time in days, A) without adjustment for differences in organ weight (i. e. log counts/liver), B) following adjustment by proportionality (i. e. log counts/gm. liver) and C) after adjustment for differences in organ weight by covariance analysis.4
The data presented in Fig. 3 Table 6 .
It should be noted that the data shown in Table ( i have been computed on the assumption that the relationship between log counts and cubic root of time in days is linear.
Perusal of the data shown in Table 6 reveals that both adjustment by propor¬ tionality and by covariance analysis greatly improve the precision. Therefore the neglection of any adjustment for differences in organ weights under our experimental conditions would be unjustifiable. It is also apparent from Table 6 , that the gain in precision due to covariance analysis over that obtained by assuming proportionality, is very slight, if any. Consequently, throughout the whole study radioactivity data will be corrected for differences in organ weight by assuming proportionality and will be expressed as log counts/gm. organ. Fig. 4 .
The differences between the two slopes is not significant (see Table 7 ), indicating that the radioactivity administered as PE32P, or as 32P, disappears with approximately the same rate from the site of injection. It is also apparent from Fig. 4 that the amount of radioactivity is much higher in the skin of PE32P-treated animals than in that of 32P-injected ones. In fact the difference between y-vsdues is highly significant (p < 0.001). Consequently, the con¬ clusion that there is a subcutaneous PE32P-depot seems to be justified. However In our attempt to remove the whole site of injection, a rather large piece of skin was extirpated from each animal. The weight of these pieces varied con¬ siderably. Assuming now, that the radioactivity injected as PE32P is concen¬ trated only within a small area of the extirpated piece of skin, it would seem reasonable to expect that radioactivity data unadjusted for differences in skin weight will provide more accurate estimates than those based on various ad¬ justments. However, the data presented in Table 6 do not seem to verify this assumption; on the contrary, it appears from the data of Table 6 that adjust¬ ment of the skin-data by proportionality or by covariance analysis will greatly improve the precision of the lines calculated. Under such circumstances it was felt justifiable to express the radioactivity data as log counts/gm. skin.
Blood.
The radioactivity data obtained in the blood are presented in Fig. 5 . Since it has not been possible to measure on the 16th day of experiment the low radioactivity in the blood of 32P-treated animals, Fig. 5 shows only the data obtained on days 1-8.
It follows from Table 7 , that the two regression lines are parallel, indicating that the radioactivity is cleared with the same rate from the blood of PE32P-and 32P-injected animals, respectively. Similarly to the situation observed in the skin, more radioactivity is present in the blood of PE32P-injected ani¬ mals that in that of 32P-treated ones, the difference being highly significant (p< 0.001).
Liver.
The data obtained in the liver are shown in Fig. 6 . The difference in slopes is highly significant (Table 7) indicating that the radioactivity disappears much slowlier from the liver of PE32P-treated animals. Since the difference in the amount of radioactivity incorporated into the liver following different treatments is highly significant, it would seem likely that a part of subcutaneously administered PE32P is rapidly accumulated in the liver.
Spleen.
-
The radioactivity data obtained in the spleen are presented in Fig. 7 .
Since it has not been possible to find a transformation yielding valid lines for the spleen-data, the computed lines are indicated with dotted lines in order to show their invalidity. Although the lines shown in Fig. 7 Due to the very small amount of radioactivity found in this organ, it was necessary to combine brains from 4 animals for each estimation. Thus every point shown in Fig. 10 Fig. 11 .
The difference in slope is significant (see Table 7 ) indicating that the radio- Fig. 12 .
It would appear from Fig. 12 that the radioactivity disappears more rapidly from the blood of PE32P-treated animals than from that of the controls. The difference between the two slopes is significant ( Table 7 ). It is also apparent that the concentration of radioactivity in the blood of PE32P-treated animals is not reduced appreciably following TCA-and ethanol-ether extraction, whereas the same extraction procedure will remove more than 50 per cent of radioactivity from the blood of 32P-treated animals. Therefore it would seem justifiable to conclude that the major part of circulating radioactivity in PE32P-treated animals -in fact -consists of PE32P.
It is obvious, however, that the upper line shown in Fig. 12 does not represent exclusively PE32P, but also some other acid insoluble-, lipid insoluble phos¬ phorus compounds, which also may contain a certain amount of radioactivity. Therefore it is not possible to estimate from the data presented in Fig. 12 Assuming that the contribution to the total radioactivity of the upper line in Fig. 12 by the phosphorus incorporated into nucleic acids or into other acid insoluble-, lipid insoluble compounds is very little or nil, it could be reasoned that in the most favourable case all the radioactivity measured will arise from PE32P. Therefore this line confidently can be regarded as the upper limit of the »true« blood concentration of PE32P (PEPmax).
On the other hand, a relatively great contribution by the radioactivity in¬ corporated into the phosphorus of nucleic acids and phosphoproteins must also be taken into consideration. It can be expected that this contribution will be maximal, when all the PE32P will be hydrolyzed into inorganic phosphate in¬ stantaneously following subcutaneous administration. In such a hypothetical case experimental conditions in the PE32P-and 32P-treated groups will be identical, and the amount of radioactivity incorporated into the acid insoluble-, lipid insoluble fraction of the blood of PE32P-treated animals, must equal that found in this fraction following the administration of 32P. Obviously, in practice the radioactivity present in the nucleic acid-and phosphoprotein frac¬ tions in the blood of PE32P-treated animals can never reach that found in the acid insoluble-, lipid insoluble fraction in 32P-treated animals. Nevertheless, making a generous allowance for the radioactivity present in other form than PE32P in this acid insoluble-, lipid insoluble fraction, by subtracting in Fig. 12 the values of the 32P-line from those of the PE32P-line, a new line can be ob¬ tained, which will represent the lower limit, (PEPmin)· Obviously, the (Table 7) . From a comparison of the data presented in Figs. 6 and 14 it also appears that the removal of acid soluble-and lipid soluble phosphorus compounds will not cause any significant change in the disappearance rate of radioactivity from the liver of PE32P-treated animals (see Table 7 ). This is circumstantial evidence in¬ dicating that measurements of total radioactivity in the liver of PE32P-treated animals will provide a rather close approximation to (Diczfalusy, 1954) indicating that the intravenous administration of PEP also gives rise to a pro¬ longed duration of effectiveness. Thus, in order to find out, whether the intra¬ venous administration of PEP is also followed by the formation of depots in the organism, it seemed desirable to study the distribution of radioactivity in spayed mice following the intravenous administration of PE32P.
In employed. Thus from the data presented in Fig. 15 Liver.
The results of the analyses on the liver are shown in Fig. 16 . Similarly to the blood data, no valid line could be obtained in the liver of 32P-treated animals. It is apparent from the data shown in Fig. 16 that much more radioactivity is present in the liver of PE32P-than in that of 32P-treated animals. The difference between the data obtained following different treat¬ ments is highly significant (p < 0.001) on each day of the experiment.
The regression coefficient for the data of PE32P-treated animals shown in Fig. 16 is higher than that obtained in the liver of PE32P-treated animals fol¬ lowing subcutaneous injection (see Table 7 ). The difference is significant on the 95 per cent probability level (p < 0.05). Thus it would appear probable that intravenously administered PE32P disappears from the liver more rapidly than the subcutaneously administered substance. Fig. 17 .
It appears from Fig. 17 that more radioactivity is present in the spleen fol¬ lowing PE32P-than after 32P-administration: the difference between the in¬ dividual points being significant at least at the 99 per cent probability level. The regression coefficient for the PE32P-line has been estimated as b = 0.005 ± 0.017. Apparently, intravenously administered PE32P is stored in the spleen similarly to the situation found in the liver. Fig. 18 .
Neither the difference in slopes nor that in the amount of radioactivity is significant (Table 7) .
A comparison of the slope obtained in the intravenously treated animals with that found in the subcutaneous experiment, does not indicate any significant difference, neither in PE32P-, nor in 32P-treated animals.
4. Comparison of the total amount of radioactivity retained in the organism following subcutaneous and intravenous administration of PE32P and 32P res¬ pectively.
When the total amount of radioactivity, which can be recovered from the whole organism following the administration of PE32P and 32P by different routes is considered, some interesting observations can be made. Fig. 19 in¬ dicates the total amount of radioactivity (expressed as a percentage of the administered dose) which could be found in the whole body of the animals on different days of the experiment. Since the data on the residual fractions from the first days of the subcutaneous experiment are missing, the lines are based only on the data obtained on the 2nd to 16th days. Fig. 19 C shows two constructed lines. These dotted lines indicate the total amount of radioactivity found in the whole organism, following the sub¬ cutaneous administration of 32P (lower line) and of PE32P (upper line), respec¬ tively. However, the amount of radioactivity originally present in the liver of these animals has been replaced by that found in the liver of intravenously treated animals. In other words, these lines represent radioactivity data from subcutaneously injected »animals« submitted to hepatectomy and subsequentlyimplanted with the liver of an intravenously injected animal.
The line obtained in this way from the data of the 32P-experiments agrees closely with the original subcutaneous 32P-line shown in Fig. 19 A. On the other hand, the line constructed from the data of PE32P-treated animals ap¬ proaches rather closely the original intravenous PE32P-line shown in Fig. 19 that the RES is involved in some way in the high uptake of PEP by the liver.
It may be expected, that a blockade of the liver will result in a higher blood level of radioactivity. Indeed the blood concentration of PE32P is much higher in the groups pretreated with india ink or with non-labelled PEP, than in the control group; again the difference between groups a and b, as well as that between a and c is highly significant (p < 0.001).
It appears also from Fig. 20 Gaddum (1953) , that for the measure¬ ment of duration time, log time is a useful effect metameter.
Personal communication.
It appears from the data compiled in Table 9 that a few animals died during the experiment in almost each of the experimental groups.
The analysis of variance for the data of Table 9 is presented in Table 10 .
From an examination of the ratio of variance due to parallelism and to error, it would appear that the hypothesis of parallelism is not contradicted by the experimental data. Consequently a common regression coefficient was cal¬ culated. The subcutaneously administered preparation was considered as »standard«, whereas the intravenously and intrasplenically injected substances as »unknown«. The estimate of relative potency (R) was calculated by using Table 9 .
Fiducial limits of error were calculated at a probability of 0.95 according to the formula given by Finney (1952) Fig. 20 .
Thus the experiment shown in Fig. 21 
